ACG to help pharma companies’ future proof ageing plant

ACG is working with its manufacturing customers to increase the life cycle of their machines, according to a company statement.

The statement said that the company is on a mission to ensure its customers do not add to their productivity concerns, and is helping them to remove any avoidable interruptions to their production while enhancing performance. ACG engineers analyse machines around the world enabling them to help owners and operators find better methods of working.

From electronic upgrades to updated OEM parts, ACG’s customers can reduce changeover and setup times, improve yield and operator safety standards. By upgrading, rather than replacing, machines can sustain less wear and tear, run more smoothly and last longer, added the statement.

Additionally, the ACG team is helping its customers with ageing machines achieve 21 CFR Part 11 compliance, the US Food and Drug Administration’s (FDA) regulation for electronic documentation and electronic signatures, it noted.

Depending on the type and age of an individual machine, the different methods for improving machine performance include production planning, condition monitoring, predictive maintenance, energy optimisation, operator augmentation and remote servicing. All are designed to help reduce costs and boost revenues and profit, concluded the statement.